Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples